Black Diamond Therapeutics, Inc. (BDTX) Financials
BDTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 132.9 million | 28.6 million |
| Dec. 31, 2025 | 143.0 million | 30.8 million |
| Sept. 30, 2025 | 157.7 million | 31.6 million |
| June 30, 2025 | 166.4 million | 33.8 million |
BDTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -10.2 million | 1.4 million |
| Dec. 31, 2025 | -6.8 million | 1.4 million |
| Sept. 30, 2025 | -7.9 million | 1.7 million |
| June 30, 2025 | -9.2 million | 1.8 million |
BDTX Net Income
No data available :(
BDTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 118.3 million | - | 14.1 million |
| Dec. 31, 2025 | 128.7 million | - | 15.1 million |
| Sept. 30, 2025 | 135.5 million | - | 16.0 million |
| June 30, 2025 | 142.8 million | - | 20.8 million |
BDTX Shares Outstanding
BDTX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 7.0 million | 4.3 million | - |
| Dec. 31, 2025 | - | 6.3 million | 4.0 million | - |
| Sept. 30, 2025 | - | 7.4 million | 3.5 million | - |
| June 30, 2025 | - | 9.3 million | 4.1 million | - |
BDTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 27000 |
| Dec. 31, 2025 | - | 66000 |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | - | 86000 |
BDTX Revenue by Segment
Graph available only for paid members. Upgrade to see it.
BDTX
Price: $1.66
52 week price:
Earnings Per Share: -0.77 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 81500
Market Capitalization: 112.9 million